DnB Asset Management AS

SEC CIK: 0001456670
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overview All 13F holders of AVXL Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2025

Holdings of AVXL by DnB Asset Management AS, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−33,261−100.0%	Sold out	Holders
Q1 2025	33,261	$285.4K	<0.1%	+33,261	New	Holders